Craig Magaret

14PUBLICATIONS
123CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityMedical biotechnology diagnostics (incl. biosensors)Molecular evolutionGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Sep 24, 2026
Relative efficacy, safety and immunogenicity of bivalent versus monovalent COVID-19 mRNA booster vaccines: a randomized trial.

|Sep 08, 2026
VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

|May 25, 2026
Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Oct 06, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett

Pageof 3

Frequent Collaborators

11 joint publications

Lawrence Corey

11 joint publications

Peter Gilbert

9 joint publications

Michal Juraska

8 joint publications

Paul T Edlefsen